Advertisement

SIRS, MODS, and the Brave New World of ICU Acronyms: Have They Helped Us?

  • John C. Marshall
Chapter
  • 240 Downloads

Abstract

Physicians like acronyms.Whether they denote a biologic entity such as TNF, a physiologic measurement such as CVP, a classification system such as APACHE, a syndrome such as AIDS, a disease such as TB, a therapy such as a GABG or EGMO, or even an investigative undertaking such as GUSTO, there is something both familiar and authoritative about distilling a complex biomedical concept into a short, manageable, and pronounceable group of initials. Acronyms both clarify and obfuscate, and serve to transform an amorphous clinical problem into one or more recognizable conditions for which the possibilities and limitations are recognized. The patient with acute respiratory failure and a diffuse infiltrate on the chest radiograph is an example: Measure the PCWP—if it is elevated it is CHF, otherwise it is ARDS. The clinical shorthand suggests a rapid diagnostic approach and a simple binary approach to management.

Keywords

Organ Dysfunction Systemic Inflammatory Response Syndrome Critical Illness Multiple Organ Failure Multiple Organ Dysfunction Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gottlieb MS, Schroff R, Schanker HM, et al: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425–1431.PubMedCrossRefGoogle Scholar
  2. 2.
    Lane WA: Chronic intestinal stasis. BMJ 1912; 1: 989–993.PubMedCrossRefGoogle Scholar
  3. 3.
    Nathens AB, Marshall JG: Sepsis, SIRS, and MODS. What’s in a name? World J Surg 1996; 20: 386–391.PubMedCrossRefGoogle Scholar
  4. 4.
    Bone RC, Balk RA, Gerra FB, et al: AGGP/SGCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644–1655.PubMedCrossRefGoogle Scholar
  5. 5.
    Vincent JL: Dear SIRS, I’m sorry to say that I don’t like you. Grit Care Med 1997; 25: 372–374.CrossRefGoogle Scholar
  6. 6.
    Majno G: The ancient riddle of (sepsis). J Infect Dis 1991; 163: 937–945.PubMedCrossRefGoogle Scholar
  7. 7.
    Rogers DE: The changing pattern of life-threatening microbial disease. N Engl J Med 1959; 261: 677–683.PubMedCrossRefGoogle Scholar
  8. 8.
    McCabe WR, Jackson GG: Gram negative bacteremia: clinical, laboratory and therapeutic observations. Arch Intern Med 1962; 110: 92–100.Google Scholar
  9. 9.
    Maclean LD, Mulligan WG, Mclean APH, Duff JH: Patterns of septic shock in man: a detailed study of 56 patients. Ann Surg 1967; 166: 543–562.PubMedCrossRefGoogle Scholar
  10. 10.
    Hinshaw LB, Archer LT, Beller-Todd BK, et al: Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res 1980; 28: 151–170.PubMedCrossRefGoogle Scholar
  11. 11.
    Meakins JL, Christou NV, Shizgal HM, Maclean LD: Therapeutic approaches to anergy in surgical patients: surgery and levamisole. Ann Surg 1979; 190: 286–296.PubMedCrossRefGoogle Scholar
  12. 12.
    The veterans administration systemic sepsis cooperative study group: effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317: 659–665.CrossRefGoogle Scholar
  13. 13.
    Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 654–658.CrossRefGoogle Scholar
  14. 14.
    Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: The methylprednisolone severe sepsis study group: sepsis syndrome: a valid clinical entity. Grit Care Med 1989; 17: 389–393.CrossRefGoogle Scholar
  15. 15.
    Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis. syndrome Ann Intern Med 1993; 119: 771–778.Google Scholar
  16. 16.
    Meade MO, Creery D, Marshall JC: Systematic review of outcome measures in randomized trials of mediator-directed therapies in sepsis. Sepsis 1997; 1: 27–33.CrossRefGoogle Scholar
  17. 17.
    Bollaert PE, Charpentier C, Levy B, Debouvarie M, Audibert G, Larean A: Reversal of late septic shock with supraphysiologlc doses of hydrocortisone. Grit Care Med 1998; 26: 627–630.CrossRefGoogle Scholar
  18. 18.
    Marshal JC, Sweeney D: Microbial infection and the septic response in critical surreal illness: sepsis, not infection, determines outcome. Arch Surg 1990; 125: 17–23.CrossRefGoogle Scholar
  19. 19.
    Rangd-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273: 117–123.CrossRefGoogle Scholar
  20. 20.
    Muckart DJJ, Bhagwanjee S: The ACCP/SCCM consensus conference definitions of the systemic inflammatory responsesyndrome (SIRS) and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25: 1789–1795.PubMedCrossRefGoogle Scholar
  21. 21.
    Suffredini AF: Endotoxin administration to humans: a model of inflammatory responses relevant to sepsis. In: Lamy M, Thijs LG (eds) Mediators of Sepsis. New York, Springer, 1992.Google Scholar
  22. 22.
    Marshall JC: Infection and the host septic response contribute independently to adverse outcome in critical illness: implications for clinical trials of mediator antagonism. In: Vincent J-L (ed) Yearbook of Intensive Care and Emergency Medicine. Berlin, Springer, 1994Google Scholar
  23. 23.
    Wortel CH, von der Mohlen MA, van Deventer SJ, et al: Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 1992; 168: 1367–1374.CrossRefGoogle Scholar
  24. 24.
    Elebute EA, Stoner HB: The grading of sepsis. Br J Surg 1983; 70: 29–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125–1128.PubMedCrossRefGoogle Scholar
  26. 26.
    Abraham E, Marshall JC: Sepsis and mediator-directed therapy: rethinking the target populations. Mol Med Today 1999; 5: 56–58.PubMedCrossRefGoogle Scholar
  27. 27.
    Safar P, De Kornfeld T, Pearson J, et al: Intensive care unit. Anesthesia 1961; 16: 275.CrossRefGoogle Scholar
  28. 28.
    Burke JF, Pontoppidan H, Welch CE: High output respiratory failure: an important cause of death ascribed to peritonitis or ileus. Ann Surg 1963; 158: 581–595.PubMedCrossRefGoogle Scholar
  29. 29.
    Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967; 2: 319–323.PubMedCrossRefGoogle Scholar
  30. 30.
    Skillman JJ, Bushnell LS, Goldman H, Silen W: Respiratory failure, hypotension, sepsis, and jaundice: a clinical syndrome associated with lethal hemorrhage and acute stress ulceration in the stomach. Am J Surg 1969; 117: 523–530.PubMedCrossRefGoogle Scholar
  31. 31.
    Baue AE: Multiple, progressive, or sequential systems failure: a syndrome of the 1970s. Arch Surg 1975; 110: 779–781.PubMedCrossRefGoogle Scholar
  32. 32.
    Eiseman B, Beart R, Norton L: Multiple organ failure. Surg Gynecol Obstet 1977; 144: 323–326.PubMedGoogle Scholar
  33. 33.
    Polk HC, Shields CL: Remote organ failure: a valid sign of occult intraabdominal infection. Surgery 1977; 81: 310–313.PubMedGoogle Scholar
  34. 34.
    Fry DE, Pearlstein L, Fulton RL, Polk HG: Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980; 115: 136–140.PubMedCrossRefGoogle Scholar
  35. 35.
    Meakins JL, Wicklund B, Forse RA, Mclean APH: The surgical intensive care unit: current concepts in infection. Surg Clin North Am 1980; 60: 117–132.PubMedGoogle Scholar
  36. 36.
    Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF: Multiple organ failure: generalized autodestructive inflammation? Arch Surg 1985; 120: 1109–1115.PubMedCrossRefGoogle Scholar
  37. 37.
    Marshall JC, Christou NV, Horn R, Meakins JL: The microbiology of multiple organ failure: the proximal GI tract as an occult reservoir of pathogens. Arch Surg 1988; 123: 309–315.PubMedCrossRefGoogle Scholar
  38. 38.
    Marshall JC: Multiple organ dysfunction syndrome (MODS). In: Sibbald WJ, Vincent J-L (eds) Clinical Trials for the Treatment of Sepsis. Berlin, Springer, 1995; 122–138.CrossRefGoogle Scholar
  39. 39.
    Rothwell PM, Udwadia ZF, Lawler PG: Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 1993; 48: 373–376.PubMedCrossRefGoogle Scholar
  40. 40.
    Baldwin WA, Allo M: Occult hypoadrenalsm in critically ill patients. Arch Surg 1993; 128: 673–676.PubMedCrossRefGoogle Scholar
  41. 41.
    Christou NV, Meakins JL, Gordon J, et al: The delayed hypersensitivity response and host resistance in surgical patients: 20 years later. Ann Surg 1995; 222: 534–548.PubMedGoogle Scholar
  42. 42.
    Marshall JC, Cook DJ, Ghristou NV, Bernard GR, Sprang CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Grit Care Med 1995; 23: 1638–1652.CrossRefGoogle Scholar
  43. 43.
    Vincent JL, Moreno R, Takala J, et al: The sepsis-related organ failure assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707–710.PubMedCrossRefGoogle Scholar
  44. 44.
    Bernard G, Doig G, Hudson G, et al: Quantification of organ dysfunction for clinical trials in sepsis. Am J Respir crit Care Med 1995; 151: A323.Google Scholar
  45. 45.
    Le Gall JR, Klar J, Lemeshow S, et al: The logistic organ dysfunction system: a new way to assess organ dysfunction in the intensive care unit. JAMA 1996; 276: 802–810.PubMedCrossRefGoogle Scholar
  46. 46.
    Marshall JG: Charting the course of critical illness: prognostication and outcome measurement in the ICU. Crit Care Med 1999; 27: 676–678.PubMedCrossRefGoogle Scholar
  47. 47.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829.PubMedCrossRefGoogle Scholar
  48. 48.
    Le Gall J-R, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAP 11) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963.PubMedCrossRefGoogle Scholar
  49. 49.
    Marshall J, Foster D, McKenna C, et al: Toronto Hospital IGU Research Group: Quantification of the multiple organ dysfunction syndrome (MODS) as a risk, factor, outcome descriptor, and surrogate measure of morbidity in the ICU. Crit Care Med 1996; 24: A53.CrossRefGoogle Scholar
  50. 50.
    Keene AR, Cullen DJ: Therapeutic intervention scoring system: update 1983. Crit Care Med 1983; 11: 1–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Tran DD, Groeneveld ABJ, van der Meulen J, Nauta JJP, Strack van Schijndel RJM, Thijs LG: Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18: 474–479.PubMedCrossRefGoogle Scholar
  52. 52.
    Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA: A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993; 104: 230–235.PubMedCrossRefGoogle Scholar
  53. 53.
    Hebert PC, Wells G, Blajchman MA, et al: Transfusion requirements in critical care investigators for the Canadian critical care trials group: a multicentre randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409–417.PubMedCrossRefGoogle Scholar
  54. 54.
    Slutsky AS, Tremblay LN: Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Grit Care Med 1998; 157: 1721–1725.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • John C. Marshall

There are no affiliations available

Personalised recommendations